Effectiveness of biosimilar pegfilgrastim in patients with lymphoma after high-dose chemotherapy and autologous stem cell transplantation: a real-life study

ObjectivesTo evaluate the efficacy of biosimilar (BIO) pegfilgrastim (PEG) in lymphoma patients after autologous stem cell transplantation (ASCT).Methods86 consecutive lymphoma patients who received BIO/PEG after ASCT were assessed. The primary endpoints of this study were the incidence of febrile n...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Barbara Loteta, Annalisa Pitino, Martina Pitea, Caterina Alati, Giovanni Tripepi, Maria Caterina Mico', Maria Pellicano', Francesca Cogliandro, Gaetana Porto, Giorgia Policastro, Giovanna Utano, Ilaria Maria Delfino, Annalisa Sgarlata, Anna Scopelliti, Aurora Idato, Giovanni Laenza, Maria Altomonte, Graziella D'Arrigo, Mercedes Gori, Massimo Martino
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2024-07-01
Ráidu:	Frontiers in Hematology
Fáttát:	lymphoma biosimilar pegfilgrastim autologous stem cell transplantation chemotherapy BIO-PEG
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/frhem.2024.1441070/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!